Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Loss of erbB signaling in oligodendrocytes alters myelin and dopaminergic function, a potential mechanism for neuropsychiatric disorders.

http://www.ncbi.nlm.nih.gov/pubmed/17483467

Several psychiatric disorders are associated with white matter defects, suggesting that oligodendrocyte (OL) abnormalities underlie some aspects of these diseases. Neuregulin 1 (NRG1) and its receptor, erbB4, are genetically linked with susceptibility to schizophrenia and bipolar disorder. In vitro studies suggest that NRG1-erbB signaling is important for OL development. To test whether erbB signaling contributes to psychiatric disorders by regulating the structure or function of OLs, we analyzed transgenic mice in which erbB signaling is blocked in OLs in vivo. Here we show that loss of erbB signaling leads to changes in OL number and morphology, reduced myelin thickness, and slower conduction velocity in CNS axons. Furthermore, these transgenic mice have increased levels of dopamine receptors and transporters and behavioral alterations consistent with neuropsychiatric disorders. These results indicate that defects in white matter can cause alterations in dopaminergic function and behavior relevant to neuropsychiatric disorders.

Pubmed ID: 17483467 RIS Download

Mesh terms: Amphetamine | Animals | Anxiety | Cyclic Nucleotide Phosphodiesterases, Type 1 | Dopamine | Mental Disorders | Mice | Mice, Transgenic | Motor Activity | Myelin Sheath | Nerve Tissue Proteins | Neural Conduction | Neuregulin-1 | Oligodendroglia | Phosphoric Diester Hydrolases | Promoter Regions, Genetic | Receptor, Epidermal Growth Factor | Receptor, ErbB-4 | Signal Transduction | Social Behavior

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NINDS NIH HHS, Id: F31 NS048630
  • Agency: NINDS NIH HHS, Id: NS7473
  • Agency: NICHD NIH HHS, Id: P30-HD 18655
  • Agency: NIMH NIH HHS, Id: P50 MH066171
  • Agency: NIMH NIH HHS, Id: P50 MH66171
  • Agency: NIMH NIH HHS, Id: R01 MH60131
  • Agency: NINDS NIH HHS, Id: R01 NS035884
  • Agency: NINDS NIH HHS, Id: R01 NS35884
  • Agency: NIMH NIH HHS, Id: R43 MH070264

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.